Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 25.29% institutional investors, 16.73% insiders, and 57.98% retail investors. Blackrock is the largest institutional shareholder, holding 5.19% of CAPR shares. SPDR® S&P Biotech ETF is the top mutual fund, with 3.03% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Capricor Therapeutics	25.29%	16.73%	57.98%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	1.63M	5.19%	$7.77M
Vanguard group	1.55M	4.94%	$7.39M
Geode capital management	641.57K	2.05%	$3.06M
Millennium management	479.51K	1.53%	$2.29M
State street	401.02K	1.28%	$1.91M
Black diamond financial	277.74K	0.84%	$3.83M
Advisor group	162.30K	0.52%	$774.17K
Caption management	130.50K	0.42%	$622.49K
Northern trust	129.61K	0.41%	$618.25K
Oppenheimer	104.23K	0.32%	$1.44M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Black diamond financial	277.74K	0.57%	$3.83M
Magnus financial group	20.00K	0.03%	$276.00K
Oppenheimer	104.23K	0.02%	$1.44M
Activest wealth management	5.00K	0.02%	$69.00K
Krilogy financial	20.80K	0.02%	$287.04K
Adar1 capital management	20.40K	0.02%	$97.31K
Coastal bridge advisors	10.89K	0.01%	$51.96K
Main street financial solutions	27.50K	0.01%	$131.18K
Caption management	130.50K	0.01%	$622.49K
Fny investment advisers	625.00	0.00%	$8.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.63M	0.00%	1.25M
Geode capital management	641.57K	0.00%	313.10K
State street	401.02K	0.00%	284.30K
Black diamond financial	277.74K	0.57%	277.74K
Millennium management	479.51K	0.00%	186.47K

Top Sellers

Holder	Shares	% Assets	Change
Renaissance	-	-	-137.50K
Goldman sachs group	82.70K	0.00%	-130.47K
Arrowstreet capital, limited partnership	-	-	-101.54K
Marshall wace, llp	-	-	-89.31K
Man group	-	-	-84.65K

New Positions

Holder	Shares	% Assets	Change	Value
Black diamond financial	277.74K	0.57%	277.74K	$3.83M
Caption management	130.50K	0.01%	130.50K	$622.49K
Nuveen asset management	34.32K	-	34.32K	$163.71K
Krilogy financial	20.80K	0.02%	20.80K	$287.04K
Adar1 capital management	20.40K	0.02%	20.40K	$97.31K

Sold Out

Holder	Change
Fmr	-1.00
Federated hermes	-68.00
Capital performance advisors llp	-91.00
Yhb investment advisors	-150.00
Macquarie group	-941.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	94	38.24%	8,369,327	30.24%	25	6.02%	56	33.33%	11	-26.67%
Jun 30, 2024	68	7.94%	6,426,234	33.35%	20	8.30%	42	-	15	66.67%
Mar 31, 2024	63	57.50%	4,818,919	20.83%	15	6.59%	42	90.91%	9	12.50%
Dec 31, 2023	40	8.11%	3,988,123	-27.56%	15	3.27%	22	83.33%	8	-27.27%
Sep 30, 2023	37	2.78%	5,505,593	112.21%	21	20.58%	12	-25.00%	11	57.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
SPDR® S&P Biotech ETF	1.38M	3.03%	-5.10K
Vanguard Total Stock Mkt Idx Inv	1.19M	2.62%	57.60K
iShares Russell 2000 ETF	1.00M	2.21%	-152.00
Vanguard Institutional Extnd Mkt Idx Tr	647.65K	1.42%	189.66K
iShares Russell 2000 Growth ETF	278.62K	0.61%	-
Fidelity Small Cap Index	261.86K	0.58%	-994.00
State St Russell Sm/Mid Cp® Indx NL Cl C	235.69K	0.52%	66.40K
Fidelity Extended Market Index	232.38K	0.51%	66.05K
Vanguard Russell 2000 ETF	173.41K	0.38%	52.35K
Direxion Daily S&P Biotech Bull 3X ETF	119.91K	0.26%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 20, 2024	Nippon Shinyaku Co Ltd	-	Buy	$15.00M
Oct 12, 2023	Musket David B	-	Buy	$1.13K
Oct 10, 2023	COLLIER EARL M JR	-	Buy	$28.30K
Oct 09, 2023	Musket David B	-	Buy	$14.33K
Oct 06, 2023	Auwaerter Paul Gisbert	-	Buy	$14.20K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	5	-

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 25.29%, followed by 16.73% insiders and 57.98% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 109.70%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock (1.63M shares, 5.19%), Vanguard group (1.55M shares, 4.94%), and Geode capital management (641.57K shares, 2.05%). Together, they hold 12.18% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Black diamond financial is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 277.74K Capricor Therapeutics shares, valued at 3.83M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Capricor Therapeutics shares, with 3.03% of its total shares outstanding invested in 1.38M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools